Digestives & Intestinal Remedies - Sweden

  • Sweden
  • In Sweden, the revenue in the Digestives & Intestinal Remedies market market reaches US$65.11m in 2024.
  • It is projected to experience an annual growth rate of 1.62% (CAGR 2024-2029).
  • When compared globally, in China leads with a revenue of US$4,408.00m in 2024.
  • In terms of per capita revenue, each person in Sweden generates US$6.10 in 2024.
  • Sweden's growing health consciousness and preference for natural remedies is driving the demand for digestive and intestinal remedies in the OTC Pharmaceuticals market.

Key regions: Brazil, India, United Kingdom, Germany, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Sweden is experiencing a steady growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Digestives & Intestinal Remedies market in Sweden are shifting towards natural and herbal remedies. Consumers are becoming more conscious about their health and are seeking products that are gentle on their bodies. This has led to an increased demand for natural digestive aids and herbal remedies that promote gut health. Additionally, there is a growing preference for products that are free from artificial additives and preservatives. Customers are looking for products that are made from organic ingredients and are sustainably sourced. This shift in customer preferences is driving the growth of the Digestives & Intestinal Remedies market in Sweden.One of the trends in the Digestives & Intestinal Remedies market in Sweden is the rise in popularity of probiotics. Probiotics are live bacteria and yeasts that are good for digestive health. They help restore the natural balance of bacteria in the gut and promote overall digestive wellness. Probiotic supplements and foods have gained significant traction in Sweden as consumers recognize their benefits. The increasing awareness about the importance of gut health and the positive impact of probiotics on digestion has led to a surge in demand for probiotic products.Another trend in the market is the growing popularity of fermented foods. Fermented foods such as sauerkraut, kefir, and kimchi are rich in probiotics and have been consumed for centuries to promote digestion. In recent years, there has been a resurgence of interest in fermented foods as consumers seek natural ways to improve their gut health. This trend has led to an increase in the availability of fermented food products in the market, catering to the growing demand.Local special circumstances in Sweden, such as the high prevalence of lactose intolerance, have also influenced the Digestives & Intestinal Remedies market. Lactose intolerance is a common condition in Sweden, with a significant portion of the population unable to digest lactose, the sugar found in milk and dairy products. This has led to a demand for lactose-free digestive aids and remedies that cater to individuals with lactose intolerance.Underlying macroeconomic factors, such as the overall health consciousness and disposable income of the population, have contributed to the growth of the Digestives & Intestinal Remedies market in Sweden. The Swedish population is known for its focus on healthy living and wellness, which has translated into increased demand for products that support digestive health. Additionally, the high disposable income of the population allows for greater spending on health and wellness products, further driving the growth of the market.In conclusion, the Digestives & Intestinal Remedies market in Sweden is experiencing growth due to changing customer preferences towards natural and herbal remedies, emerging trends such as the popularity of probiotics and fermented foods, local special circumstances such as lactose intolerance, and underlying macroeconomic factors including the health consciousness and disposable income of the population.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)